Target species
Species: cattle
Sub-category: calves and adult cows
Age: From 3 months
Indications for use
For the active immunisation of cattle from 3 months of age against Bovine Herpes Virus type 1 (BoHV-1) to reduce the clinical signs of infectious bovine rhinotracheitis (IBR) and field virus excretion.
Onset of Immunity:
21 days after completion of the basic vaccination scheme.
Duration of immunity: 6 months after completion of the basic vaccination scheme
Contra-indications
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Special warnings for each target species
None
Special precautions for use
Special precautions for use in animals
Vaccinate healthy animals only.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
None.
Adverse reactions
Common adverse reactions:
A slight increase in body temperature up to 1° C is common within 4 days following vaccination. Occasionally, an increase in rectal temperature up to 1.63º C in adult cows and up to 2.18º C in calves may be observed. This transient rise in temperature is spontaneously resolved within 48 hours without treatment and it is not related to a febrile process.
A transient inflammation at the inoculation site is common in cattle within 72 hours post-vaccination. This slight swelling lasts for less than 24 hours in most cases.
Vary rare adverse reactions:
Vaccination might exceptionally cause hypersensitivity reactions. In such cases, an appropriate symptomatic treatment should be administered
Northern Ireland Adverse Reaction Update
Rare adverse reactions:
Hypersensitivity reactions, including anaphylaxis (sometimes fatal), have been reported rarely. In such cases, an appropriate symptomatic treatment should be administered.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reactions (GB only:during the course of one treatment))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports)
Use during pregnancy, lactation or lay
Can be used during pregnancy and lactation.
Interactions
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Amounts to be administered and administration route
Cattle: from the age of 3 months onwards.
Reconstitute the lyophilised tablet with the entire contents of the enclosed solvent to obtain a suspension for injection.
Recommended vaccination programme:
The recommended initial dose is 1 injection of 2 ml of the reconstituted vaccine per animal. The animal should be revaccinated 3 weeks later with the same dose.
Thereafter a single booster dose of 2 ml should be administered every six months.
The method of administration is by intramuscular route, in the neck muscles. The injections should be preferably administered on the alternate sides of the neck. The solvent should be allowed to warm to a temperature between 15 ºC to 20ºC before reconstitution of the lyophilised tablet. Shake well before use. Avoid the introduction of contamination during reconstitution and use. Use only sterile needles and syringes for administration.
Overdose (symptoms, emergency procedures, antidotes), if necessary
No adverse reactions except those mentioned in previous section were observed after the administration of a 10-fold vaccine dose.
Withdrawal periods
Zero Days